Elefante Mark B Buys 2,309 Shares of UnitedHealth Group Incorporated $UNH

Elefante Mark B grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 35.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,750 shares of the healthcare conglomerate’s stock after acquiring an additional 2,309 shares during the quarter. UnitedHealth Group accounts for approximately 1.9% of Elefante Mark B’s portfolio, making the stock its 24th largest holding. Elefante Mark B’s holdings in UnitedHealth Group were worth $3,021,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Brighton Jones LLC increased its position in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC raised its stake in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. CMT Capital Markets Trading GmbH bought a new position in UnitedHealth Group during the second quarter valued at about $340,000. D.A. Davidson & CO. raised its position in UnitedHealth Group by 33.7% in the second quarter. D.A. Davidson & CO. now owns 56,801 shares of the healthcare conglomerate’s stock worth $17,720,000 after acquiring an additional 14,315 shares during the period. Finally, Brookstone Capital Management grew its position in shares of UnitedHealth Group by 29.8% during the 2nd quarter. Brookstone Capital Management now owns 17,251 shares of the healthcare conglomerate’s stock valued at $5,382,000 after acquiring an additional 3,960 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 0.4%

Shares of NYSE:UNH opened at $289.39 on Friday. The company has a market cap of $262.14 billion, a price-to-earnings ratio of 21.94, a PEG ratio of 1.33 and a beta of 0.41. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $606.36. The firm has a fifty day moving average price of $317.88 and a two-hundred day moving average price of $323.89. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.82.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The company had revenue of $113.22 billion during the quarter, compared to analyst estimates of $113.38 billion. During the same quarter last year, the company earned $6.81 earnings per share. The firm’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have weighed in on UNH shares. UBS Group reduced their price objective on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. Sanford C. Bernstein reissued an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Mizuho cut their target price on shares of UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a research report on Thursday, February 5th. Truist Financial dropped their price target on shares of UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, February 2nd. Finally, TD Cowen boosted their target price on shares of UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a report on Thursday, October 30th. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $372.13.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.